Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Spider Plot

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon Oct 19, 2022 4:00pm

137 Views

Post# 35034603

RE:RE:RE:RE:RE:RE:RE:Spider Plot

Where one seller away from another leg down in absence of any encouraging information but then again maybe it's the desired path from the company for the option orgy coming up. They should be able to give somthing encouraging atm... if recruitmenet is online to be completed by the end of Q1 2023 the must at least have 50% done by now... say that at least...

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China